We are live on ! Find out more
TCBP

TC BioPharm (Holdings) plc American Depositary Shares

Delisted

TCBP was delisted on the 21st of March, 2025.

3 hedge funds and large institutions have $244K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% less capital invested

Capital invested by funds: $646K → $244K (-$402K)

73% less funds holding

Funds holding: 113 (-8)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
3
Holders Change
-8
Holders Change %
-72.73%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$235K +$417K +370 +398%
TRCT
2
Tower Research Capital (TRC)
New York
$8.78K +$19.2K +17 New
JP Morgan Chase
3
JP Morgan Chase
New York
$282 +$1.13K +1 New
Wells Fargo
4
Wells Fargo
California
$159 -$4.51K -4 Closed
CAM
5
Cresset Asset Management
Illinois
-$10.8K -8 Closed
CAG
6
Csenge Advisory Group
Florida
-$11.2K -8 Closed
MWM
7
Modera Wealth Management
New Jersey
-$466K -5 Closed
Citadel Advisors
8
Citadel Advisors
Florida
-$5.65K -4 Closed
TSS
9
Two Sigma Securities
New York
-$5.76K -4 Closed
XT
10
XTX Topco
Cayman Islands
-$5.68K -4 Closed
Renaissance Technologies
11
Renaissance Technologies
New York
-$5K -3 Closed
UBS Group
12
UBS Group
Switzerland
-$1.51K -1 Closed
CS
13
Clear Street
New York
-$569

TCBP Hedge Fund Activity: Q4 2023 in Review

3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q4 2023, worth a combined $244K — down 62% from $646K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TCBP and 2 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Armistice Capital, adding an estimated $417K. The largest seller was Modera Wealth Management, exiting entirely with an estimated $466K sold.

  • 3 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q4 2023, down from 11 in Q3 2023.
  • Funds reported $244K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q4 2023, down 62% quarter-over-quarter.
  • 2 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q4 2023 and 9 closed out, a net change of -7 holders.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q4 2023 was Armistice Capital, an estimated $417K added.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q4 2023 was Modera Wealth Management, an estimated $466K sold.

Based on aggregated 13F filings for Q4 2023.